We are live on ! Find out more
CAS

CTC Alternative Strategies Portfolio holdings

AUM $44M
1-Year Est. Return 43.15%
This Fund
S&P 500
This Quarter Est. Return
+13.62%
1 Year Est. Return
+43.15%
3 Year Est. Return
+76.07%
5 Year Est. Return
10 Year Est. Return
AUM
$160M
AUM Growth
+$112M
Cap. Flow
+$102M
Cap. Flow %
63.7%
Top 10 Hldgs %
78.69%
Holding
196
New
123
Increased
4
Reduced
2
Closed
67

Sector Composition

Rank Sector Weight
1 Energy 5.34%
2 Industrials 4.18%
3 Financials 4.18%
4 Consumer Discretionary 3.42%
5 Technology 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRCH icon
76
Porch Group
PRCH
$1.8B
$103K 0.06%
+24,000
New +$71.5K
OCGN icon
77
Ocugen
OCGN
$434M
$103K 0.06%
+62,800
New +$52.6K
REAL icon
78
The RealReal
REAL
$1.5B
$102K 0.06%
+26,100
New +$62.2K
ESPR
79
DELISTED
Esperion Therapeutics
ESPR
$99.4K 0.06%
+37,100
New +$90.2K
RUM icon
80
RUM Group Inc
RUM
$1.76B
$97.8K 0.06%
+12,100
New +$78.1K
TCRX icon
81
TScan Therapeutics
TCRX
$52M
$87.3K 0.05%
+11,000
New +$69.2K
IREN icon
82
Iris Energy
IREN
$14.7B
$85.9K 0.05%
+15,900
New +$86.4K
TSHA icon
83
Taysha Gene Therapies
TSHA
$1.89B
$85.5K 0.05%
+29,800
New +$62.1K
ILPT
84
Industrial Logistics Properties Trust
ILPT
$586M
$84.1K 0.05%
+19,600
New +$79.6K
CATX icon
85
Perspective Therapeutics
CATX
$342M
$83.2K 0.05%
+6,990
New +$59.6K
REAX icon
86
Real Brokerage
REAX
$466M
$82.1K 0.05%
+26,300
New +$72.2K
HNST icon
87
The Honest Company
HNST
$586M
$79K 0.05%
+19,500
New +$65.8K
IVVD icon
88
Invivyd
IVVD
$218M
$73.3K 0.05%
+16,500
New +$68.2K
AQST icon
89
Aquestive Therapeutics
AQST
$494M
$72.4K 0.05%
+17,000
New +$56.6K
APLT
90
DELISTED
Applied Therapeutics
APLT
$70.7K 0.04%
+10,400
New +$46.7K
CRDF icon
91
Cardiff Oncology
CRDF
$77.2M
$66.2K 0.04%
+12,400
New +$33K
UP icon
92
Wheels Up
UP
$198M
$65.7K 0.04%
+1,145
New +$75.4K
FSP
93
Franklin Street Properties
FSP
$46.8M
$65.6K 0.04%
+28,900
New +$68.9K
ATOS icon
94
Atossa Therapeutics
ATOS
$23.5M
$65.3K 0.04%
+2,420
New +$38.9K
PBYI icon
95
Puma Biotechnology
PBYI
$454M
$64.1K 0.04%
+12,100
New +$65.2K
VXRT
96
DELISTED
Vaxart
VXRT
$64.1K 0.04%
+49,300
New +$51.7K
TLS icon
97
Telos
TLS
$358M
$63.2K 0.04%
+15,200
New +$60.2K
AMTX icon
98
Aemetis
AMTX
$124M
$62.9K 0.04%
+10,500
New +$39.9K
TE
99
T1 Energy
TE
$1.63B
$61.8K 0.04%
+36,800
New +$58.3K
CTV
100
DELISTED
Innovid Corp.
CTV
$60.9K 0.04%
+24,473
New +$42.3K

Similar funds

CTC Alternative Strategies's Q1 2024 Portfolio in Review

As of Q1 2024, CTC Alternative Strategies held 196 positions worth $160M, up 233% from $48.2M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

CTC Alternative Strategies deployed $102M of net new capital in Q1 2024, opening 123 new positions and adding to 4 existing holdings. Its largest new stake was iShares TIPS Bond ETF: 228,000 shares worth $24.5M.

By sector, the portfolio is most concentrated in Energy at 5.3% of assets, up from 0% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Erie Indemnity, an estimated $511K trimmed.

  • CTC Alternative Strategies's largest Q1 2024 buy was iShares TIPS Bond ETF: 228,000 shares worth $24.5M.
  • CTC Alternative Strategies added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2024, an estimated $21.2M increase.
  • CTC Alternative Strategies's biggest Q1 2024 reduction was Erie Indemnity, cutting an estimated $511K.
  • CTC Alternative Strategies fully exited RPT Realty Common Shares of Beneficial Interest (MD) in Q1 2024, selling an estimated $2.97M.
  • CTC Alternative Strategies's ten largest holdings make up 79% of its $160M portfolio in Q1 2024.
  • CTC Alternative Strategies opened 123 new positions and closed 67 in Q1 2024.
  • CTC Alternative Strategies's portfolio value rose 233% quarter-over-quarter to $160M.

Based on CTC Alternative Strategies's 13F filing for Q1 2024, filed 9 May 2024.